We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
184 hedge funds and large institutions have $480M invested in ANI Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 71 increasing their positions, 43 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
149% more call options, than puts
Call options by funds: $8.13M | Put options by funds: $3.26M
65% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 43
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
30% more capital invested
Capital invested by funds: $369M → $480M (+$111M)
5% more funds holding
Funds holding: 175 → 184 (+9)
4.15% more ownership
Funds ownership: 56.85% → 60.99% (+4.1%)
Holders
184
Holders Change
+9
Holders Change %
+5.14%
% of All Funds
4.21%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
28
Increased
71
Reduced
43
Closed
19
Calls
$8.13M
Puts
$3.26M
Net Calls
+$4.87M
Net Calls Change
+$8.1M
Top Buyers
| 1 |
BlackRock
New York
|
+$5.92M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$4.93M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$2.94M |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$2.61M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$2.27M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.77M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.49M |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.43M |
| 4 |
JG
Jefferies Group
New York
|
-$1.7M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$1.14M |
